MedTrace Logo

PALLIATIVE ASSESSMENT COHORT IN THE GERIATRIC EMERGENCY SETTING

NCT06911411 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-04-04

No results posted yet for this study

Summary

The PALMA project is part of a larger palliative research program COPAL in Capital Region of Denmark led by Professor Tom Møller. PALMA aims to improve palliative care for geriatric patients transitioning from emergency-hospital to primary care. The project addresses the lack of a systematic approach for assessing and managing palliative symptoms in geriatric patients to enhance communication between hospitals and municipal health care services.

The PALMA cohort investigates the applicability of systematic palliative assessment (EORTC-C15 PAL) in the geriatric emergency setting combined with measures of frailty, socio-demographic risks, and cross-sectoral healthcare support.

Conditions

  • Geriatric
  • Palliative Care
  • Socio-demographic Risk
  • Frailty at Older Adults
  • Loneliness
  • Collaborative Care
  • Transition of Care

Interventions

OTHER

Prospective observational cohort study.

No systematic approach exists for symptom assessment, management, and reporting in delivered basic palliative care within the Danish healthcare system, implying considerable variation in hospital-based palliative care. The PALMA study consists of two superior phases divided in a development and an implementation stage that anchors basic palliative assessment and management within existing geriatric workflows and cross-sectoral collaborative care. The PALMA cohort will test the applicability of the EORTC-C15-PAL questionnaire along with measures of clinical frailty and sociodemographic risk factors. The development phase will enable the development of a clinical algorithm for elderly patients' need for cross-sectoral palliation care planning.

OTHER

A prospective observational cohort study

Observational design

Sponsors & Collaborators

  • The Danish Health Authority

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-12-30
Completion
2026-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06911411 on ClinicalTrials.gov